Comparative analysis was performed at both nucleic acid and protein vaccine levels to provides a reference for the "glycosylation quality control" of SARS-CoV-2 RBD vaccines. For instance, monitoring the glycoform distribution at the N343 site (e.g., ensuring the proportion of the M5 glycoform is ≥3...
ORGANISM(S): Homo sapiens (Human)
